Gainers
- NovaBay Pharmaceuticals NBY shares moved upwards by 25.3% to $1.93 during Friday's pre-market session. The company's market cap stands at $3.9 million.
- Onconova Therapeutics ONTX stock increased by 22.52% to $0.86. The market value of their outstanding shares is at $18.0 million.
- Aziyo Biologics AZYO stock increased by 21.68% to $2.02. The company's market cap stands at $32.7 million.
- Cyclo Therapeutics CYTH shares moved upwards by 14.52% to $0.81. The market value of their outstanding shares is at $8.5 million.
- CytoMed Therapeutics GDTC stock increased by 12.61% to $3.75. The company's market cap stands at $41.0 million.
- Compass Therapeutics CMPX shares rose 11.51% to $3.1. The market value of their outstanding shares is at $392.1 million.
Losers
- Candel Therapeutics CADL shares decreased by 14.9% to $1.2 during Friday's pre-market session. The market value of their outstanding shares is at $34.7 million.
- Vallon Pharmaceuticals VLON stock decreased by 13.05% to $0.4. The company's market cap stands at $5.3 million.
- Aditxt ADTX shares decreased by 12.43% to $0.88. The company's market cap stands at $3.7 million.
- Plus Therapeutics PSTV shares fell 12.0% to $0.27. The market value of their outstanding shares is at $9.5 million. As per the press release, Q1 earnings came out yesterday.
- Sonnet BioTherapeutics SONN stock decreased by 11.26% to $0.27. The market value of their outstanding shares is at $5.4 million.
- Vincerx Pharma VINC stock fell 9.1% to $0.91. The company's market cap stands at $19.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CADLCandel Therapeutics Inc
$8.65-13.2%
CMPXCompass Therapeutics Inc
$1.380.73%
CYTHCyclo Therapeutics Inc
$0.62981.58%
GDTCCytoMed Therapeutics Ltd
$2.35-3.69%
NBYNovaBay Pharmaceuticals Inc
$0.51001.17%
PSTVPlus Therapeutics Inc
$1.056.06%
SONNSonnet BioTherapeutics Holdings Inc
$1.57-1.24%
VINCVincerx Pharma Inc
$0.1966-4.93%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in